Cutera, Inc. (CUTR)

$2.395

-0.25

(-9.28%)

Market is closed - opens 8 PM, 26 Feb 2024

Performance

  • $2.36
    $2.62
    $2.40
    downward going graph

    1.67%

    Downside

    Day's Volatility :9.92%

    Upside

    8.4%

    downward going graph
  • $1.38
    $33.31
    $2.40
    downward going graph

    42.5%

    Downside

    52 Weeks Volatility :95.86%

    Upside

    92.79%

    downward going graph

Returns

PeriodCutera, Inc.
3 Months
22.19%
6 Months
-74.97%
1 Year
-92.52%
3 Years
-93.61%

Highlights

Market Capitalization
52.8M
Book Value
- $3.47
Earnings Per Share (EPS)
-3.86
PEG Ratio
9.05
Wall Street Target Price
7.67
Profit Margin
-31.08%
Operating Margin TTM
-35.66%
Return On Assets TTM
-8.5%
Return On Equity TTM
-4447.26%
Revenue TTM
246.4M
Revenue Per Share TTM
12.66
Quarterly Revenue Growth YOY
-4.7%
Gross Profit TTM
139.8M
EBITDA
-55.4M
Diluted Eps TTM
-3.86
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.46
EPS Estimate Next Year
-2.93
EPS Estimate Current Quarter
-0.63
EPS Estimate Next Quarter
-0.45

Analyst Recommendation

Buy
    58%Buy
    33%Hold
    8%Sell
Based on 12 Wall street analysts offering stock ratings for Cutera, Inc.(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
4
4
4
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 220.25%

Current $2.40
Target $7.67

Company Financials

FY17Y/Y Change
Revenue
151.5M
↑ 28.32%
Net Income
30.0M
↑ 1063.87%
Net Profit Margin
19.8%
↑ 17.62%
FY18Y/Y Change
Revenue
162.7M
↑ 7.41%
Net Income
-30.8M
↓ 202.59%
Net Profit Margin
-18.91%
↓ 38.71%
FY19Y/Y Change
Revenue
181.7M
↑ 11.67%
Net Income
-12.3M
↓ 59.87%
Net Profit Margin
-6.8%
↑ 12.11%
FY20Y/Y Change
Revenue
147.7M
↓ 18.73%
Net Income
-23.9M
↑ 93.37%
Net Profit Margin
-16.17%
↓ 9.37%
FY21Y/Y Change
Revenue
231.3M
↑ 56.6%
Net Income
2.1M
↓ 108.64%
Net Profit Margin
0.89%
↑ 17.06%
FY22Y/Y Change
Revenue
252.4M
↑ 9.14%
Net Income
-82.3M
↓ 4093.21%
Net Profit Margin
-32.62%
↓ 33.51%
Q1 FY22Q/Q Change
Revenue
58.0M
↓ 11.6%
Net Income
-15.1M
↑ 284.8%
Net Profit Margin
-26.1%
↓ 20.1%
Q2 FY22Q/Q Change
Revenue
64.2M
↑ 10.7%
Net Income
-47.3M
↑ 212.22%
Net Profit Margin
-73.61%
↓ 47.51%
Q3 FY22Q/Q Change
Revenue
62.8M
↓ 2.2%
Net Income
-12.1M
↓ 74.33%
Net Profit Margin
-19.32%
↑ 54.29%
Q4 FY22Q/Q Change
Revenue
67.4M
↑ 7.24%
Net Income
-7.8M
↓ 35.82%
Net Profit Margin
-11.56%
↑ 7.76%
Q1 FY23Q/Q Change
Revenue
67.4M
↑ 0.0%
Net Income
-7.8M
↑ 0.0%
Net Profit Margin
-11.56%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
61.2M
↓ 9.11%
Net Income
-31.6M
↑ 306.32%
Net Profit Margin
-51.69%
↓ 40.13%
FY17Y/Y Change
Total Assets
111.2M
↑ 21.1%
Total Liabilities
46.3M
↑ 50.26%
FY18Y/Y Change
Total Assets
97.6M
↓ 12.23%
Total Liabilities
51.3M
↑ 10.59%
FY19Y/Y Change
Total Assets
113.7M
↑ 16.49%
Total Liabilities
67.8M
↑ 32.28%
FY20Y/Y Change
Total Assets
132.7M
↑ 16.7%
Total Liabilities
75.9M
↑ 11.88%
FY21Y/Y Change
Total Assets
280.3M
↑ 111.17%
Total Liabilities
223.7M
↑ 194.94%
FY22Y/Y Change
Total Assets
521.0M
↑ 85.87%
Total Liabilities
536.2M
↑ 139.66%
Q1 FY22Q/Q Change
Total Assets
266.7M
↓ 4.85%
Total Liabilities
223.5M
↓ 0.09%
Q2 FY22Q/Q Change
Total Assets
424.1M
↑ 59.02%
Total Liabilities
400.2M
↑ 79.04%
Q3 FY22Q/Q Change
Total Assets
428.2M
↑ 0.96%
Total Liabilities
412.7M
↑ 3.11%
Q4 FY22Q/Q Change
Total Assets
521.0M
↑ 21.68%
Total Liabilities
536.2M
↑ 29.93%
Q1 FY23Q/Q Change
Total Assets
521.0M
↑ 0.0%
Total Liabilities
536.2M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
463.8M
↓ 10.97%
Total Liabilities
533.0M
↓ 0.6%
FY17Y/Y Change
Operating Cash Flow
14.3M
↑ 617.22%
Investing Cash Flow
17.7M
↓ 621.64%
Financing Cash Flow
-31.6M
↓ 833.04%
FY18Y/Y Change
Operating Cash Flow
307.0K
↓ 97.85%
Investing Cash Flow
10.8M
↓ 39.11%
Financing Cash Flow
788.0K
↓ 102.5%
FY19Y/Y Change
Operating Cash Flow
-2.2M
↓ 822.15%
Investing Cash Flow
1.1M
↓ 90.1%
Financing Cash Flow
1.4M
↑ 79.44%
FY20Y/Y Change
Operating Cash Flow
-17.0M
↑ 664.82%
Investing Cash Flow
6.4M
↑ 498.78%
Financing Cash Flow
31.3M
↑ 2113.44%
FY21Y/Y Change
Operating Cash Flow
1.2M
↓ 107.28%
Investing Cash Flow
-944.0K
↓ 114.78%
Financing Cash Flow
117.5M
↑ 275.51%
FY22Y/Y Change
Operating Cash Flow
-67.0M
↓ 5524.7%
Investing Cash Flow
-194.2M
↑ 20470.13%
Financing Cash Flow
242.9M
↑ 106.71%
Q1 FY22Q/Q Change
Operating Cash Flow
-29.6M
↓ 1211.68%
Investing Cash Flow
-74.4M
↑ 11650.24%
Financing Cash Flow
-2.4M
↓ 803.74%
Q2 FY22Q/Q Change
Operating Cash Flow
-481.0K
↓ 98.38%
Investing Cash Flow
-137.2M
↑ 84.42%
Financing Cash Flow
155.0M
↓ 6427.77%
Q3 FY22Q/Q Change
Operating Cash Flow
-19.9M
↑ 4033.68%
Investing Cash Flow
-7.8M
↓ 94.28%
Financing Cash Flow
-1.4M
↓ 100.93%
Q4 FY22Q/Q Change
Operating Cash Flow
-17.0M
↓ 14.36%
Investing Cash Flow
25.2M
↓ 421.44%
Financing Cash Flow
91.9M
↓ 6457.37%
Q1 FY23Q/Q Change
Operating Cash Flow
-17.0M
↑ 0.0%
Investing Cash Flow
25.2M
↑ 0.0%
Financing Cash Flow
91.9M
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-31.3M
↑ 83.63%
Investing Cash Flow
45.2M
↑ 79.49%
Financing Cash Flow
-153.0K
↓ 100.17%

Technicals Summary

Sell

Neutral

Buy

Cutera, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • RTW INVESTMENTS, LLC

    9.23%
  • BlackRock Inc

    6.28%
  • Millennium Management LLC

    6.26%
  • PURA VIDA INVESTMENTS, LLC

    6.25%
  • Point72 Asset Management, L.P.

    6.24%
  • Gamco Investors, Inc. Et Al

    5.72%

Corporate Announcements

  • Cutera, Inc. Earnings

    Cutera, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra

Organization
Cutera, Inc.
Employees
540
CEO
Dr. Michael A. Karavitis Ph.D.
Industry
Health Technology

FAQs